A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
Authors
Keywords
-
Journal
Internal and Emergency Medicine
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-10
DOI
10.1007/s11739-021-02734-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome
- (2020) Marie‐Hélène Odièvre et al. AMERICAN JOURNAL OF HEMATOLOGY
- Treatment of COVID-19 Patients with Convalescent Plasma
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
- (2020) Jeanne Lenzer BMJ-British Medical Journal
- Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
- (2020) Xinyi Xia et al. BLOOD
- Use of convalescent plasma in hospitalized patients with COVID-19: case series
- (2020) Livia Hegerova et al. BLOOD
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
- (2020) Hassan Abolghasemi et al. TRANSFUSION AND APHERESIS SCIENCE
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role
- (2020) Giuseppe Magro MEDICAL HYPOTHESES
- Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
- (2020) Anup Agarwal et al. BMJ-British Medical Journal
- Ebola virus disease: An emerging and re-emerging viral threat
- (2019) Manuel Rojas et al. JOURNAL OF AUTOIMMUNITY
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Immune suppressive properties of artemisinin family drugs
- (2016) Lifei Hou et al. PHARMACOLOGY & THERAPEUTICS
- Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
- (2016) O. Garraud et al. TRANSFUSION CLINIQUE ET BIOLOGIQUE
- Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
- (2015) Jan D. Lünemann et al. Nature Reviews Neurology
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Plasma components: properties, differences, and uses
- (2012) Richard John Benjamin et al. TRANSFUSION
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started